List of Aerpio Therapeutics patents

Patents where

Current Assignee

Name

Aerpio Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10220048 Compositions and methods for treating ocular diseases	Patent 10220048 was granted and assigned to Aerpio Therapeutics on March, 2019 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	10220048	March 5, 2019
‌ US Patent 9539245 Combination of immunotherapies with activators of Tie-2	Patent 9539245 was granted and assigned to Aerpio Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9539245	January 10, 2017
‌ US Patent 10329357 Treatment of ocular disease	Patent 10329357 was granted and assigned to Aerpio Therapeutics on June, 2019 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	10329357	June 25, 2019
‌ US Patent 9278930 Methods for increasing the stabilization of hypoxia inducible factor-α	Patent 9278930 was granted and assigned to Aerpio Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9278930	March 8, 2016
‌ US Patent 9096555 Methods for treating vascular leak syndrome	Patent 9096555 was granted and assigned to Aerpio Therapeutics on August, 2015 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9096555	August 4, 2015
‌ US Patent 8999325 Treatment of ocular disease	Patent 8999325 was granted and assigned to Aerpio Therapeutics on April, 2015 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	8999325	April 7, 2015
‌ US Patent 9795594 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 9795594 was granted and assigned to Aerpio Therapeutics on October, 2017 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9795594	October 24, 2017
‌ US Patent RE46592 Human protein tyrosine phosphatase inhibitors and methods of use	Patent RE46592 was granted and assigned to Aerpio Therapeutics on October, 2017 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	RE46592	October 31, 2017
‌ US Patent 8946232 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 8946232 was granted and assigned to Aerpio Therapeutics on February, 2015 by the United States Patent and Trademark Office.		Aerpio Therapeutics	United States Patent and Trademark Office	8946232	February 3, 2015
‌ US Patent 8188125 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 8188125 was granted and assigned to Aerpio Therapeutics on May, 2012 by the United States Patent and Trademark Office.		Aerpio Therapeutics	United States Patent and Trademark Office	8188125	May 29, 2012
‌ US Patent 8258311 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 8258311 was granted and assigned to Aerpio Therapeutics on September, 2012 by the United States Patent and Trademark Office.		Aerpio Therapeutics	United States Patent and Trademark Office	8258311	September 4, 2012
‌ US Patent 9440963 Compositions, formulations and methods for treating ocular diseases	Patent 9440963 was granted and assigned to Aerpio Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9440963	September 13, 2016
‌ US Patent 9126958 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 9126958 was granted and assigned to Aerpio Therapeutics on September, 2015 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9126958	September 8, 2015
‌ US Patent 9284285 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 9284285 was granted and assigned to Aerpio Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9284285	March 15, 2016
‌ US Patent 10150811 Methods for treating vascular leak syndrome and cancer	Patent 10150811 was granted and assigned to Aerpio Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	10150811	December 11, 2018
‌ US Patent 9994560 HPTP-β inhibitors	Patent 9994560 was granted and assigned to Aerpio Therapeutics on June, 2018 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9994560	June 12, 2018
‌ US Patent 10253094 Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions	Patent 10253094 was granted and assigned to Aerpio Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	10253094	April 9, 2019
‌ US Patent 9926367 Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof	Patent 9926367 was granted and assigned to Aerpio Therapeutics on March, 2018 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9926367	March 27, 2018
‌ US Patent 9174950 Compounds, compositions, and methods for preventing metastasis of cancer cells	Patent 9174950 was granted and assigned to Aerpio Therapeutics on November, 2015 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9174950	November 3, 2015
‌ US Patent 9949956 Compounds, compositions, and methods for preventing metastasis of cancer cells	Patent 9949956 was granted and assigned to Aerpio Therapeutics on April, 2018 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9949956	April 24, 2018
‌ US Patent 8846685 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 8846685 was granted and assigned to Aerpio Therapeutics on September, 2014 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	8846685	September 30, 2014
‌ US Patent 8895563 Human protein tyrosine phosphatase inhibitors and methods of use	Patent 8895563 was granted and assigned to Aerpio Therapeutics on November, 2014 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	8895563	November 25, 2014
‌ US Patent 8329916 Human protein tyrosine phosphatase inhibitors and method of use	Patent 8329916 was granted and assigned to Aerpio Therapeutics on December, 2012 by the United States Patent and Trademark Office.		Aerpio Therapeutics	United States Patent and Trademark Office	8329916	December 11, 2012
‌ US Patent 9388135 Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-ones	Patent 9388135 was granted and assigned to Aerpio Therapeutics on July, 2016 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	9388135	July 12, 2016
‌ US Patent 8883832 Compounds, compositions, and methods for preventing metastasis of cancer cells	Patent 8883832 was granted and assigned to Aerpio Therapeutics on November, 2014 by the United States Patent and Trademark Office.	Aerpio Therapeutics	Aerpio Therapeutics	United States Patent and Trademark Office	8883832	November 11, 2014

Results per page:

35 results

0 selected

35 results

0 selected